Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types-Reference-Cited by-同舟云学术

Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types

Published:2014-04 Issue:4 Volume:43 Page:323-327
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Farrell David J.,Flamm Robert K.,Sader Helio S.,Jones Ronald N.

Funder

Basilea Pharmaceutica International AG (Basel, Switzerland)

Achaogen

Aires

American Proficiency Institute (API)

Anacor

Astellas

AstraZeneca

Bayer

bioMérieux

Cempra

Cerexa

ContraFect

Cubist Pharmaceuticals

Daiichi

Dipexium

Enanta

Furiex

GlaxoSmithKline

Johnson & Johnson

LegoChem Biosciences Inc.

Meiji Seika Kaisha

Merck

Nabriva

Novartis

Paratek

Pfizer

PPD Therapeutics

Premier Research Group

Rempex

Rib-X Pharmaceuticals

Seachaid

Shionogi

The Medicines Co.

Theravance

Thermo Fisher

TREK Diagnostics

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference27 articles.

1. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007;Hidron;Infect Control Hosp Epidemiol,2008

2. Improved understanding of factors driving methicillin-resistant Staphylococcus aureus epidemic waves;Chatterjee;Clin Epidemiol,2013

3. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections;Hersh;Arch Intern Med,2008

4. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children;Liu;Clin Infect Dis,2011

5. Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus;Nannini;Curr Opin Pharmacol,2010

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ceftobiprole mono-therapy versus combination or non-combination regimen of standard antibiotics for the treatment of complicated infections: A systematic review and meta-analysis;Diagnostic Microbiology and Infectious Disease;2024-07

2. Prevalence of tigecycline resistance in methicillin-resistant Staphylococcus aureus: a systematic review and meta-analysis;Diagnostic Microbiology and Infectious Disease;2024-01

3. Population Pharmacokinetic and Pharmacodynamic Analysis for Maximizing the Effectiveness of Ceftobiprole in the Treatment of Severe Methicillin-Resistant Staphylococcal Infections;Microorganisms;2023-12-12

4. QSAR analysis of five generations of cephalosporins to establish the structural basis of activity against methicillin-resistant and methicillin-sensitive Staphylococcus aureus;Molecular Diversity;2023-09-21

5. Antimicrobial activity of ceftobiprole and comparator agents when tested against gram-positive and -negative organisms collected across China (2016–2018);BMC Microbiology;2022-11-26